#drug-repurposing

The best nystagmus drugs might already be on the shelf

I turned my fund’s data tooling on my own nystagmus: 3,200 papers, 669 findings, off-patent drugs nobody has trialed.

ISPOR 2026 Spotlight: Identifying Drug Repurposing Opportunities with AI Literature Review

AI-Assisted Drug Repurposing

Repurposed Molecules: Can Existing Drugs Find New Roles in Neurological Diseases?

Modern drug development is a long, expensive, and uncertain process. For this reason, one increasingly important strategy in biomedical…

Drug Repurposing Market Hits 14.76% CAGR; Is AI Rewriting the Future of Drug Discovery?

The global drug repurposing market is entering a transformative phase as pharmaceutical companies, biotech startups, and AI-driven research…

Can an AI Agent Run a Drug Repurposing Project? We Built One to Find Out.

Meet RepurAgent, a multi-agent AI system that doesn’t just suggest drug candidates, but plans the experiments, analyzes the results, and…

Generative AI and Its Benefits

Generative AI has incredible benefits in the real world, so why isn’t it being taught in schools? While Generative AI is not a new concept…

Why Drug Repurposing Programs Fail Mechanism Audits — And What to Do Before Governance Review

The promise of drug repurposing is straightforward: an asset with a known safety profile, applied to a new indication, shortens the path to…

Drug Repurposing Market 2035: $2.5 Billion Boom; Are We Reinventing Medicine Faster Than Ever?

Drug Repurposing Market 2035: $2.5 Billion Boom; Are We Reinventing Medicine Faster Than Ever?

AI in Drug Repurposing Market Set to Hit $8.12

The pharmaceutical industry is undergoing a quiet but powerful shift. AI in drug repurposing is no longer experimental; it is becoming…

AI in Drug Repurposing Market Set to Hit $8.12

The pharmaceutical industry is undergoing a silent but powerful transformation. Artificial intelligence is no longer just a support tool…

Can silibinin target both SARS‑CoV‑2 and endothelial dysfunction?

Insights from molecular docking and in vitro endothelial models

How Generative AI and the new Era of Drug Repurposing and Repositioning

Unlocking Hidden Potential: How AI is Revolutionizing Drug Repurposing

The journey of bringing a new drug to market is notoriously long, expensive, and fraught with failure. On average, it takes over a decade…

Generative AI in drug discovery

Following a breakout year of rapid growth, generative AI has been widely, and justifiably, described as an undisputed game-changer for…